Point-of-Care Diagnosis and Prognostication of Cryptococcal Meningitis With the Cryptococcal Antigen Lateral Flow Assay on Cerebrospinal Fluid
| dc.contributor.author | Kabanda, Taseera | |
| dc.contributor.author | Siedner, Mark J. | |
| dc.contributor.author | Klausner, Jeffrey D. | |
| dc.contributor.author | Muzoora, Conrad | |
| dc.contributor.author | Boulware, David R. | |
| dc.date.accessioned | 2020-02-25T06:11:30Z | |
| dc.date.available | 2020-02-25T06:11:30Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | The cryptococcal antigen (CRAG) lateral flow assay (LFA) had 100% sensitivity and specificity on cerebrospinal fluid samples. Pretreatment LFA titers correlated with quantitative cultures (R2 = 0.7) and predicted 2- and 10-week mortality. The CRAG LFA is an accurate diagnostic assay for CSF and should be considered for point-of-care diagnosis of cryptococcal meningitis. | en_US |
| dc.identifier.citation | Kabanda, T., Siedner, M. J., Klausner, J. D., Muzoora, C., & Boulware, D. R. (2014). Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. Clinical infectious diseases, 58(1), 113-116. | en_US |
| dc.identifier.uri | http://ir.must.ac.ug/handle/123456789/510 | |
| dc.language.iso | en | en_US |
| dc.publisher | Oxford University Press | en_US |
| dc.subject | HIV | en_US |
| dc.subject | cryptococcal meningitis | en_US |
| dc.subject | diagnosis | en_US |
| dc.subject | pointof-care | en_US |
| dc.subject | sub-Saharan Africa | en_US |
| dc.title | Point-of-Care Diagnosis and Prognostication of Cryptococcal Meningitis With the Cryptococcal Antigen Lateral Flow Assay on Cerebrospinal Fluid | en_US |
| dc.type | Article | en_US |